ST2 requires Th2-, but not Th17-, type airway inflammation in epicutaneously antigen-sensitized mice

Allergology International

Volumn 61, Issue 2, 2012, Pages 265-273

  Morita, Hideaki ^a,b   Arae, Ken ^b,c   Ohno, Tatsukuni ^b   Kajiwara, Naoki ^d   Oboki, Keisuke ^b   Matsuda, Akio ^b   Suto, Hajime ^d   Okumura, Ko ^d   Sudo, Katsuko ^e   Takahashi, Takao ^a   Matsumoto, Kenji ^b   Nakae, Susumu ^b,d,f,g,h  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c KYORIN UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f Frontier Research Initiative   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Asthma; Eosinophils; Epicutaneous sensitization; IL 33; ST2

Indexed keywords

CELL RECEPTOR; EOSINOPHIL PEROXIDASE; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 33; MYELOPEROXIDASE; OVALBUMIN; ST2 RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOMETRY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LUNG LAVAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; TH17 CELL; TH2 CELL;

EID: 84862688077     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-OA-0379     Document Type: Article

References (49)

1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-27.
2. Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ. Early life risk factors for adult asthma: A birth cohort study of subjects at risk. J Allergy Clin Immunol 2001; 108:720-5.
3. Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ. A birth cohort study of subjects at risk of atopy: Twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 2002;165:176-80.
4. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy 2000;55:240-5.
5. Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006;118:214-9.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
7. Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008;121:1203-9.
8. Marenholz I, Kerscher T, Bauerfeind A et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol 2009;123:911-6.
9. Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009;124:485-93.
10. Kodama M, Asano K, Oguma T et al. Strain-specific phenotypes of airway inflammation and bronchial hyperresponsiveness induced by epicutaneous allergen sensitization in BALB/c and C57BL_6 mice. Int Arch Allergy Immunol 2010;152:67-74.
11. He R, Oyoshi MK, Jin H, Geha RS. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 2007;104:15817-22.
12. He R, Kim HY, Yoon J et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol 2009;124:761-70.
13. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998;101:1614-22.
14. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010;59:143-60.
15. Baekkevold ES, Roussigne M, Yamanaka T et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003;163:69-79.
16. Luthi AU, Cullen SP, McNeela EA et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009;31:84-98.
17. Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 2009;106:9021-6.
18. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem2009;284:19420-6.
19. Pushparaj PN, Tay HK, H'Ng S C et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 2009;106:9773-8.
20. Gudbjartsson DF, Bjornsdottir US, Halapi E et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41:342-7.
21. Moffatt MF, Gut IG, Demenais F et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010;363:1211-21.
22. Reijmerink NE, Postma DS, Bruinenberg M et al. Association of IL1RL1, IL-18R1, and IL-18RAP gene cluster polymorphisms with asthma and atopy. J Allergy Clin Immunol 2008;122:651-4.
23. Shimizu M, Matsuda A, Yanagisawa K et al. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 2005;14:2919-27.
24. Ali M, Zhang G, Thomas WR et al. Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 2009;73:206-12.
25. Castano R, Bosse Y, Endam LM, Desrosiers M. Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am J Rhinol Allergy 2009;23:377-84.
26. Sakashita M, Yoshimoto T, Hirota T et al. Association of serum interleukin-33 level and the interleukin-33 genetic variant with japanese cedar pollinosis. Clin Exp Allergy 2008;38:1875-81.
27. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1_ST2-deficient mice demonstrate the importance of T1_ST2 in developing primary T helper cell type 2 responses. J ExpMed 2000;191:1069-76.
28. Nakae S, Lunderius C, Ho LH, Schafer B, Tsai M, Galli SJ. TNF can contribute to multiple features of ovalbumininduced allergic inflammation of the airways in mice. J Allergy Clin Immunol 2007;119:680-6.
29. Oboki K, Ohno T, Kajiwara N et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 2010;107:18581-6.
30. Nakae S, Suto H, Berry GJ, Galli SJ. Mast cell-derived tnf can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged otii mice. Blood 2007;109:3640-8.
31. Wahlgren CF. Itch and atopic dermatitis: An overview. J Dermatol 1999;26:770-9.
32. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
33. Guo L, Wei G, Zhu J et al. IL-1 family members and stat activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 2009;106:13463-8.
34. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009;113:1526-34.
35. Ho LH, Ohno T, Oboki K et al. IL-33 induces IL-13 production by mouse mast cells independently of igefcepsilonri signals. J Leukoc Biol 2007;82:1481-90.
36. Moro K, Yamada T, Tanabe M et al. Innate production of T(h)2 cytokines by adipose tissue-associated c-kit(+) sca-1(+) lymphoid cells. Nature 2010;463:540-4.
37. Kuroiwa K, Li H, Tago K et al. Construction of elisa system to quantify human ST2 protein in sera of patients. Hybridoma 2000;19:151-9.
38. Oshikawa K, Kuroiwa K, Tago K et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164: 277-81.
39. Prefontaine D, Lajoie-Kadoch S, Foley S et al. Increased expression of IL-33 in severe asthma: Evidence of expression by airway smooth muscle cells. J Immunol 2009;183: 5094-103.
40. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002;32: 1520-6.
41. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem2007;282:26369-80.
42. Hoshino K, Kashiwamura S, Kuribayashi K et al. The absence of interleukin 1 receptor-related T1_ST2 does not affect T helper cell type 2 development and its effector function. J ExpMed 1999;190:1541-8.
43. Kurowska-Stolarska M, Kewin P, Murphy G et al. Il-33 induces antigen-specific IL-5+ T cells and promotes allergicinduced airway inflammation independent of IL-4. J Immunol 2008;181:4780-90.
44. Mangan NE, Dasvarma A, McKenzie AN, Fallon PG. T1_ ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur J Immunol 2007;37:1302-12.
45. Meisel C, Bonhagen K, Lohning M et al. Regulation and function of T1_ST2 expression on CD4+ t cells: Induction of type 2 cytokine production by T1_ST2 cross-linking. J Immunol 2001;166:3143-50.
46. Coyle AJ, Lloyd C, Tian J et al. Crucial role of the interleukin 1 receptor family member T1_ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999;190:895-902.
47. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008;57:121-34.
48. Dong C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat Rev Immunol 2006;6:329-33.
49. Yagami A, Orihara K, Morita H et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 2010;185:5743-50.